Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia

BACKGROUND: Genotype 3 (GT3) is a common chronic hepatitis C (CHC) genotype in Asia. Direct-acting antiviral (DAA) regimens have high cure rates, but real-world results are limited for Asia. AIM: To determine the real-world effectiveness of DAAs for patients with CHC GT3 in Asia. METHODS: A systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Bin, Ji, Fanpu, Yeo, Yee Hui, Ogawa, Eiichi, Stave, Christopher D, Dang, Shuangsuo, Li, Zongfang, Furusyo, Norihiro, Cheung, Ramsey C, Nguyen, Mindie H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104766/
https://www.ncbi.nlm.nih.gov/pubmed/30147941
http://dx.doi.org/10.1136/bmjgast-2018-000209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104766/
https://www.ncbi.nlm.nih.gov/pubmed/30147941
http://dx.doi.org/10.1136/bmjgast-2018-000209

Ejemplares similares